Altshuler Shaham’s Usana Health Sciences USNA Stock Holding History

Altshuler Shaham’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-379	Closed	-$22.2K	–	318
2023 Q3	$22.2K	Sell	379 -55	-13%	-$3.44K	﹤0.01%	224
2023 Q2	$27.4K	Buy	+434	New	+$27.6K	﹤0.01%	259
2022 Q3	–	Sell	-923	Closed	-$67K	–	537
2022 Q2	$67K	Buy	923 +473	+105%	+$35.2K	﹤0.01%	198
2022 Q1	$36K	Sell	450 -25	-5%	-$2.25K	﹤0.01%	457
2021 Q4	$48K	Sell	475 -33	-6%	-$3.29K	﹤0.01%	439
2021 Q3	$47K	Buy	508 +112	+28%	+$10.8K	﹤0.01%	425
2021 Q2	$41K	Buy	396 +15	+4%	+$1.51K	﹤0.01%	477
2021 Q1	$37K	Buy	+381	New	+$34.7K	﹤0.01%	341
2020 Q4	–	Sell	-341	Closed	-$25K	–	468
2020 Q3	$25K	Buy	341 +117	+52%	+$9.39K	﹤0.01%	309
2020 Q2	$16K	Buy	+224	New	+$17.6K	﹤0.01%	276

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Altshuler Shaham's USNA Position: Q4 2023 in Review

Altshuler Shaham sold out of Usana Health Sciences (USNA) in Q4 2023, closing a stake of 379 shares — an estimated $22.2K sold.

Altshuler Shaham first reported a position in USNA in Q2 2020 and held it in 10 quarters. The position peaked at $67K in Q2 2022. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2023.

Altshuler Shaham reported no remaining Usana Health Sciences position as of Q4 2023 after selling out during the quarter.
Altshuler Shaham sold 379 Usana Health Sciences shares in Q4 2023, an estimated $22.2K.
Altshuler Shaham first reported a position in Usana Health Sciences in Q2 2020 and held it in 10 quarters.
Altshuler Shaham's Usana Health Sciences position peaked at $67K in Q2 2022.
167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2023.

Based on Altshuler Shaham's 13F filing for Q4 2023, filed 7 Feb 2024.